Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.
OBJECTIVE
Abatacept is the only agent currently approved to treat rheumatoid arthritis (RA) that targets the co-stimulatory signal required for full T-cell activation. No studies have been conducted on its effect on the synovium, the primary site of pathology. The aim of this study was to determine the synovial effect of abatacept in patients with RA and an inadequate response to tumour necrosis factor alpha (TNFalpha) blocking therapy.


METHODS
This first mechanistic study incorporated both dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and arthroscopy-acquired synovial biopsies before and 16 weeks after therapy, providing tissue for immunohistochemistry and quantitative real-time PCR analyses.


RESULTS
Sixteen patients (13 women) were studied; all had previously failed TNFalpha-blocking therapy. Fifteen patients completed the study. Synovial biopsies showed a small reduction in cellular content, which was significant only for B cells. The quantitative PCR showed a reduction in expression for most inflammatory genes (Wald statistic of p<0.01 indicating a significant treatment effect), with particular reduction in IFNgamma of -52% (95% CI -73 to -15, p<0.05); this correlated well with MRI improvements. In addition, favourable changes in the osteoprotegerin and receptor activator of nuclear factor kappa B levels were noted. DCE-MRI showed a reduction of 15-40% in MRI parameters.


CONCLUSIONS
These results indicate that abatacept reduces the inflammatory status of the synovium without disrupting cellular homeostasis. The reductions in gene expression influence bone positively and suggest a basis for the recently demonstrated radiological improvements that have been seen with abatacept treatment in patients with RA.
Buch
M H
MH
Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, UK.
Boyle
D L
DL
Rosengren
S
S
Saleem
B
B
Reece
R J
RJ
Rhodes
L A
LA
Radjenovic
A
A
English
A
A
Tang
H
H
Vratsanos
G
G
O'Connor
P
P
Firestein
G S
GS
Emery
P
P
D000069594:Abatacept; D018501:Antirheumatic Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D006801:Humans; D018796:Immunoconjugates / Q000494:pharmacology*; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000235:genetics
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D000069594:Abatacept
J Rheumatol. 2007 Mar;34(3):620-2
17343309
N Engl J Med. 1999 Jan 28;340(4):253-9
9920948
Nature. 2003 May 15;423(6937):356-61
12748655
Arthritis Rheum. 2002 Feb;46(2):366-72
11840438
Curr Opin Rheumatol. 2002 May;14(3):204-11
11981314
Arthritis Rheum. 2000 Jan;43(1):38-47
10643698
Arthritis Rheum. 2005 Jan;52(1):61-72
15641091
J Exp Med. 1994 Aug 1;180(2):631-40
7519245
Ann Rheum Dis. 2008 Mar;67(3):402-8
17644541
Arthritis Rheum. 1995 Oct;38(10):1457-65
7575695
Arthritis Rheum. 2004 Dec;50(12):3783-91
15593225
Arthritis Rheum. 1996 Jul;39(7):1077-81
8670314
Arthritis Rheum. 2007 Mar;56(3):772-8
17328049
Arthritis Rheum. 2006 Sep;54(9):2793-806
16947627
Curr Rheumatol Rep. 2005 Oct;7(5):400-6
16174492
Arthritis Rheum. 2003 Aug;48(8):2155-62
12905468
Arthritis Rheum. 2003 Jan;48(1):35-45
12528101
Arthritis Rheum. 2004 Aug;50(8):2428-32
15334454
Ann Rheum Dis. 1999 Jun;58(6):342-9
10340958
N Engl J Med. 2005 Sep 15;353(11):1114-23
16162882
J Magn Reson Imaging. 1997 Jan-Feb;7(1):91-101
9039598
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
N Engl J Med. 2001 Mar 22;344(12):907-16
11259725
J Exp Med. 1991 Sep 1;174(3):561-9
1714933
Ann Intern Med. 2006 Jun 20;144(12):865-76
16785475
Ann Rheum Dis. 1994 Jan;53(1):39-44
8311554
Arthritis Res Ther. 2003;5(6):R352-60
14680510
N Engl J Med. 2000 Nov 30;343(22):1594-602
11096166
J Clin Immunol. 1990 Jul;10(4):192-9
2145318
Rheumatology (Oxford). 2005 Feb;44(2):157-63
15637039